Greenstein Leonard M. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Mar 23, 2023
Insider Transaction Report
Form 4
Greenstein Leonard M.
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-03-21$12.89/sh−326$4,202→ 32,463 total - Sale
Common Stock
2023-03-22$12.64/sh−332$4,196→ 32,131 total - Sale
Common Stock
2023-03-23$12.15/sh−346$4,204→ 31,785 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.